UCLA’s Resnick Neuropsychiatric Hospital earns prestigious Magnet designation for nursing excellence

Resnick staff celebrating
Nursing staff celebrating the honor. The hospital became one of the first psychiatric facilities to receive Magnet designation from the American Nurses Credentialing Center.

The Stewart and Lynda Resnick Neuropsychiatric Hospital at UCLA has attained Magnet recognition, the nation’s highest honor for excellence in nursing.

The hospital is one of the first psychiatric facilities to receive the prestigious designation, which is awarded by the American Nurses Credentialing Center. Only about 7 percent of all U.S. hospitals have achieved Magnet recognition.

The Resnick Neuropsychiatric Hospital, a 74-bed acute psychiatric hospital, is a key part of UCLA Health and the major psychiatry teaching facility of the David Geffen School of Medicine at UCLA and Ronald Reagan UCLA Medical Center.

"Magnet designation is a hard-won honor that requires a total team effort to deliver the highest quality of care to our patients," said Karen Grimley, the chief nurse executive of UCLA Health. "It reflects the tremendous dedication of the hospital nursing staff to both their profession and the patients they serve."

To achieve initial Magnet recognition, organizations must undergo a rigorous evaluation that demonstrates qualitative and quantitative evidence regarding patient care and outcomes, and a thorough on-site analysis that assesses the quality of nursing leadership and coordination and collaboration across specialties.

"We have always known that the Resnick nursing staff is tremendously committed to providing the best care for our patients, and it is fantastic to have this recognition,"’ said Patricia Matos, the hospital's chief nursing officer.

UCLA Health - Santa Monica Medical Center, received Magnet recognition in 2016, and Ronald Reagan UCLA Medical Center has achieved Magnet designation three times, most recently in 2015. The designation runs for a period of four years, after which institutions must reapply.

Related Content

Articles:

Media Contact

David Olmos
310-267-8276
[email protected]
Share: